Skip to content
10-Q

Quarterly Report

CVS HEALTH Corp CVS

0000064803-25-000037

← back to feed
Filed
Oct 29, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 22, 2025 1.27B sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.27B sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.27B sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.26B sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.26B sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $0
Stock Repurchased Q3 2025 · Sep 30, 2024 $3.02B
Dividends Paid Q3 2025 · Sep 30, 2025 $2.55B
Dividends Paid Q3 2025 · Sep 30, 2024 $2.54B
Capex Q3 2025 · Sep 30, 2025 $2.05B
Capex Q3 2025 · Sep 30, 2024 $2.01B
Operating Cash Flow Q3 2025 · Sep 30, 2025 $7.25B
Operating Cash Flow Q3 2025 · Sep 30, 2024 $7.25B
Short Term Debt Q3 2025 · Sep 30, 2025 $1.25B
Short Term Debt Q3 2025 · Dec 31, 2024 $2.12B
Short Term Investments Q3 2025 · Sep 30, 2025 $2.13B
Short Term Investments Q3 2025 · Dec 31, 2024 $2.41B
Cash And Equivalents Q3 2025 · Sep 30, 2025 $9.1B
Cash And Equivalents Q3 2025 · Dec 31, 2024 $8.59B
Stockholders Equity Q3 2025 · Sep 30, 2025 $72.93B
Stockholders Equity Q3 2025 · Dec 31, 2024 $75.56B
Current Liabilities Q3 2025 · Sep 30, 2025 $92.7B
Current Liabilities Q3 2025 · Dec 31, 2024 $84.61B
Total Liabilities Q3 2025 · Sep 30, 2025 $182.22B
Total Liabilities Q3 2025 · Dec 31, 2024 $177.49B
Current Assets Q3 2025 · Sep 30, 2025 $77.11B
Current Assets Q3 2025 · Dec 31, 2024 $68.65B
Total Assets Q3 2025 · Sep 30, 2025 $255.33B
Total Assets Q3 2025 · Dec 31, 2024 $253.22B
Eps Diluted Q3 2025 · Sep 30, 2025 −$3.13
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.93
Eps Diluted Q3 2025 · Sep 30, 2024 $0.07
Eps Diluted Q3 2025 · Sep 30, 2024 $2.35
Eps Basic Q3 2025 · Sep 30, 2025 −$3.13
Eps Basic Q3 2025 · Sep 30, 2025 −$0.93
Eps Basic Q3 2025 · Sep 30, 2024 $0.07
Eps Basic Q3 2025 · Sep 30, 2024 $2.36
Net Income Q3 2025 · Sep 30, 2025 −$3.98B
Net Income Q3 2025 · Sep 30, 2025 −$1.18B
Net Income Q3 2025 · Sep 30, 2024 $87M
Net Income Q3 2025 · Sep 30, 2024 $2.97B
Operating Income Q3 2025 · Sep 30, 2025 −$3.21B
Operating Income Q3 2025 · Sep 30, 2025 $2.55B
Operating Income Q3 2025 · Sep 30, 2024 $832M
Operating Income Q3 2025 · Sep 30, 2024 $6.15B